Results 121 to 130 of about 92,938,436 (228)

Examining a central mechanism whereby undernutrition inhibits GnRH secretion via KNDy neurons. [PDF]

J Reprod Dev
Nestor CC, Kennedy A.
europepmc   +1 more source

Moving beyond promethazine: Advancing precision in antiemetic therapy. [PDF]

SAGE Open Med
Ryan MF, Lagasse C.
europepmc   +1 more source

Synthesis and neurokinin antagonist activity of 2-benzylidene- and 2- benzyl-3-benzylamino quinuclidines

, 1993
Molecular modeling studies based on the potent NK-1 antagonist CP-96,345 led us to the identification of some 2-benzylidene- and 2-benzyl-3- benzylaminoquinuclidine derivatives as potential antagonists at the NK receptor subtypes.
Santini A., Vittoria A., GRECO, GIOVANNI, Turbanti L., SANTAGADA, VINCENZO, Renzetti A. R., CALIENDO, GIUSEPPE, Pedone C., PERISSUTTI, ELISA, Benedetti E., Silipo C.   +10 more
core  

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Impact of Evolving Antiemetic Prophylaxis on Chemotherapy-Induced Nausea and Vomiting (CINV): A Five-Year Comparative Study in Sichuan, China (2018-2023). [PDF]

Cancer Manag Res
Xiong W, Zhang W, Zhao Q, Zheng Y, Xie K, Miao J, Chen L, Li T, Cao W, Zhu, Huang M, Li C, Wang Y, Gui Y, Li Q, Cao C, Yang Y, Du C, Gao Y, Zhou Y, Zhang H, Le X, Chen P, Jiang M, Li P, Yang J, Wang Y, Zhu J, He L.   +28 more
europepmc   +1 more source

Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancer. [PDF]

J Manag Care Spec Pharm
Kamat S, Brown BR, Cohen SA, Vyas A.
europepmc   +1 more source

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas. [PDF]

J Am Heart Assoc
Lopez AG, Duparc C, Renouf S, D'Agostino M, De Sousa K, Amar L, Defortescu G, Manceau G, Sabourin JC, Fernandes-Rosa FL, Zennaro MC, Meatchi T, Nicolas G, Louiset E, Lefebvre H.   +14 more
europepmc   +1 more source

Neurokinin Antagonists to Treat Vasomotor Symptoms-Possible Implications for Long-Term Health and Disease. [PDF]

J Clin Med
Cagnacci A, Xholli A, Fiamberti M, Londero AP.   +3 more
europepmc   +1 more source

Elinzanetant: First Approval. [PDF]

Drugs
Lee A.
europepmc   +1 more source

The Involvement of the Peptidergic Systems in Breast Cancer Development. [PDF]

Cancers (Basel)
Sánchez ML, Robinson P, Italia Z, Hoang T, Muñoz M, Coveñas R.   +5 more
europepmc   +1 more source